Intravesical BCG immunotherapy for Non-Muscle Invasive Bladder Cancer during COVID-19 pandemic: Mutual impact and implications. (2022). Chemical Biology Letters, 9(2), 267. https://pubs.thesciencein.org/journal/index.php/cbl/article/view/267